Clinical Trials Sponsored by EpiCept Corporation

Total 6497 results

Incyte Corporation

Completed

A Study of INCB018424 Phosphate Cream in Subjects With Vitiligo

Vitiligo

United States
Incyte Corporation

Completed

A Study of INCMGA00012 in Squamous Carcinoma of the Anal Canal Following Platinum-Based Chemotherapy (POD1UM-202)

Squamous Cell Carcinoma of Anal Canal

Spain, United Kingdom, United States, Germany, Belgium, France, Denmark, Italy, Norway
Cerus Corporation

Completed

In Vivo Study to Assess the Recovery and Survival of Radiolabeled Autologous INTERCEPT Apheresis Platelet Components Suspended in 100% Plasma Stored for up to 7 Days

Healthy

United States
Symvivo Corporation

Completed

Evaluating the Safety, Tolerability and Immunogenicity of bacTRL-Spike Vaccine for Prevention of COVID-19

COVID-19

Australia
Yuhan Corporation

Completed

Rosuvastatin/Amlodipine vs Atorvastatin/Amlodipine in Hypertension Patient With Dyslipidemia (CORONA)

Hypertension | Dyslipidemias

Korea, Republic of
Masimo Corporation

Completed

Desaturation Validation of INVSENSOR00039

Healthy

United States
Incyte Corporation

No longer available

Expanded Access Use of Itacitinib to Treat a Single Patient With Aplastic Anemia

Aplastic Anemia
Incyte Corporation

Completed

A Study of the Safety of INCB054707 in Participants With Hidradenitis Suppurativa

Hidradenitis Suppurativa

United States
Glaukos Corporation

Terminated

A Prospective Evaluation of Glaucoma Subjects Treated With Two Second Generation iStents and One iStent Supra (GCF-041)

Glaucoma, Open-Angle

Germany
Glaukos Corporation

Terminated

iStent Inject in OAG Subjects on 2 Pre-op Topical Ocular Hypotensive Medications

Primary Open Angle Glaucoma (POAG)

Brazil
Glaukos Corporation

Completed

Two Second-Generation Trabecular Micro-bypass Stents to Treat Glaucoma Subjects on One Hypotensive Medication

Open Angle Glaucoma

Armenia
Glaukos Corporation

Completed

Subjects With Open-angle Glaucoma, Pseudoexfoliative Glaucoma, or Ocular Hypertension Naïve to Medical and Surgical Therapy, Treated With Two Trabecular Micro-bypass Stents (iStent Inject) or Travoprost

Open-angle Glaucoma

Armenia
Glaukos Corporation

Completed

A Prospective Evaluation of Open-Angle Glaucoma Subjects on Two Topical Hypotensive Medications Treated With One Suprachoroidal Stent

Subject With Primary Open-angle Glaucoma (POAG)

Armenia
Glaukos Corporation

Completed

One, Two, or Three iStents for the Reduction of Intraocular Pressure in Open-angle Glaucoma Subjects

Primary Open Angle Glaucoma (POAG)

Armenia
Glaukos Corporation

Completed

Open-angle Glaucoma Subjects on One Ocular Hypotensive Medication Randomized to Treatment With Two Trabecular Micro-bypass Stents or Selective Laser Trabeculoplasty

Open-angle Glaucoma

Armenia
Glaukos Corporation

Completed

Open-angle Glaucoma Subjects on One Topical Hypotensive Medication Randomized to Treatment With One or Two Trabecular Micro-bypass Stents in Conjunction With Cataract Surgery

Open-angle Glaucoma

Armenia
Incyte Corporation

Completed

To Evaluate the Safety, and Pharmacokinetics of Parscaclisib in Participants With Normal Hepatic Function and Hepatic Impairment.

Advanced Malignancies

United States
Incyte Corporation

Withdrawn

To Evaluate Efficacy and Safety of Parsaclisib Plus Either Rituximab or Obinutuzumab in R/R Follicular Lymphoma (FL) and Marginal Zone Lymphoma (MZL) (CITADEL-302)

Marginal Zone Lymphoma (MZL) | Follicular Lymphoma ( FL)
Yuhan Corporation

Completed

A Study to Evaluate the Pharmacokinetics and Safety of YHD1119 in Subjects With Renal Impairment and Healthy Subjects

Healthy Volunteer | Renal Impairments

Korea, Republic of
Yuhan Corporation

Completed

BE Study of Two Formulations of Rivaroxaban 2.5 mg in Healthy Subjects

Healthy Volunteer

Korea, Republic of
Topcon Corporation

Completed

Triton Reference Database

Healthy Eyes

United States
Topcon Corporation

Completed

NW500 Non-Mydriatic Retinal Camera Clinical Performance Study

Fundus Photography

United States
Incyte Corporation

Terminated

Pemigatinib + Pembrolizumab vs Pemigatinib Alone vs Standard of Care for Urothelial Carcinoma (FIGHT-205)

Metastatic Urothelial Carcinoma | Unresectable Urothelial Carcinoma

Spain, France, United States, Italy, Japan, Ireland, Slovakia, Austria, Belgium, Canada, Finland, Germany, Poland, Portugal, Romania, United Kingdom
Glaukos Corporation

Completed

Multicenter Investigation of the Glaukos® Suprachoroidal Stent Model G3 In Conjunction With Cataract Surgery

Primary Open-angle Glaucoma

United States
Incyte Corporation

Completed

Myelofibrosis and Essential Thrombocythemia Observational Study (MOST)

MPN (Myeloproliferative Neoplasms)

United States, Puerto Rico
Incyte Corporation

Terminated

Efficacy and Safety of Pemigatinib in Participants With Solid Tumors With FGFR Mutations or Translocations (FIGHT-208)

Advanced or Metastatic Solid Tumors | FGFR Mutations | FGFR Translocations

United States
Masimo Corporation

Completed

Oxygen Reserve Index: Utility as Early Warning for Desaturation in Morbidly Obese Patients

Surgery | Morbid Obesity

United States
Candela Corporation

Completed

Pulsed Dye Laser Treatment and Oxymetazoline Hydrochloride (HCL) 1% Cream for Erythematotelangiectatic Rosacea

Erythematotelangiectatic Rosacea

United States
Incyte Corporation

Completed

A Phase 2 Safety and Efficacy Study of INCB050465 in Subjects With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (CITADEL-202)

Lymphoma

United States, Spain, Korea, Republic of, Belgium, Australia, Czechia, Poland, Canada, France, Italy, United Kingdom
Incyte Corporation

Terminated

A Study of Epacadostat and Nivolumab in Combination With Immune Therapies in Participants With Advanced or Metastatic Malignancies (ECHO-208)

Solid Tumors

United States
Incyte Corporation

Completed

Open Label, Safety and Efficacy Study of Topical Investigational Drug to Treat Patients With Psoriasis

Psoriasis

United States
Spectranetics Corporation

Completed

Stellarex Vascular E-Registry (SAVER)

Peripheral Arterial Disease

Belgium, Germany, France, United Kingdom, Austria, Italy
Incyte Corporation

Completed

A Study of Ruxolitinib in Combination With Corticosteroids for the Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease (REACH-1)

Graft-versus-host Disease (GVHD)

United States
Masimo Corporation

Terminated

Rainbow Acoustic Monitoring (RAM) in Patients Weighing up to 10kg Comparison Study

Respiration Rate

United States
FemPulse Corporation

Completed

Pilot Phase for an Acute Evaluation of a Non-Implantable Electrical Continence Device

Urinary Bladder, Overactive

United States
Enimmune Corporation

Completed

A Study to Evaluate the Immunogenicity and Safety of EV71 Vaccine in Pediatric Subjects

Enterovirus Infections

Taiwan
Masimo Corporation

Completed

Validation of Noninvasive Hemoglobin, Comparison of PVI to Standard Methods, and Validation of Clinical Efficacy of ORI

Surgery

United States
Glaukos Corporation

Active, not recruiting

Multicenter Post-Approval Study Of The Glaukos® iStent® Trabecular Micro-Bypass Stent System In Conjunction With Cataract Surgery

Primary Open Angle Glaucoma

United States
Amorepacific Corporation

Completed

Clinical Study to Investigate the Sleep Quality Enhancing Effect of GABA

Sleep Disturbance

Korea, Republic of
Geron Corporation

Completed

Study to Evaluate Activity of 2 Dose Levels of Imetelstat in Participants With Intermediate-2 or High-Risk Myelofibrosis (MF) Previously Treated With Janus Kinase (JAK) Inhibitor

Myelofibrosis

United States, France, Italy, United Kingdom, Belgium, Germany, Taiwan, Spain, Israel, Korea, Republic of, Canada
Masimo Corporation

Terminated

Oxygen Reserve Index (ORi) Validation of INVSENSOR00014

Healthy

United States
Masimo Corporation

Completed

Noninvasive Hemoglobin Repeatability and Reproducibility in a Blood Donation Setting

Healthy | Anemia

United States
Tomey Corporation

Completed

Comparative Study of the Cornea/Anterior Segment OCT CASIA2 and the RTVue XR OCT Avanti With AngioVue Software

Glaucoma | Cataract

United States
Masimo Corporation

Completed

Oxygen Reserve Index (ORi) Validation of INVSENSOR00025

Healthy

United States
Incyte Corporation

Completed

GRAVITAS-301: A Study of Itacitinib or Placebo in Combination With Corticosteroids for Treatment of Acute Graft-Versus-Host Disease

Graft-versus-host Disease (GVHD)

United States, Spain, Belgium, France, Italy, Korea, Republic of, Finland, United Kingdom, Germany, Israel, Switzerland, Austria, Australia, Czechia, Greece, New Zealand, Poland, Portugal, Taiwan
Masimo Corporation

Completed

Noninvasive Hemoglobin Testing, Prospective Blood Donors

Healthy | Anemia

United States
Masimo Corporation

Withdrawn

Monitoring Noninvasively for Infusion and Transfusion Optimization

Hypovolemia | Post Operative Hemorrhage | Transfusion Related Complication | Blood Transfusion Associated Adverse Reactions
Omeros Corporation

Completed

A Randomized Study in Children Ages Birth Through Three Years Undergoing Unilateral Cataract Extraction With or Without Lens Replacement (ILR7)

Congenital Cataract | Unilateral Cataract Extraction

United States
Yuhan Corporation

Completed

Anagre Cap. in Patients With High-Risk Essential Thrombocythemia

Essential Thrombocythemia

Korea, Republic of
Masimo Corporation

Completed

Desaturation Validation of INVSENSOR00028

Healthy

United States

3

Subscribe